A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

Health Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

With only seven members, iGEM Eindhoven forms a small but determined student team that aims to help shape the future of ...

Data from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

Kenya has completely run out of essential medical supplies—including HIV medicines, testing kits, and vaccines—putting ...